Gelteq Ltd.

GELS

Offer Price Offer Size 3-Year Outlook Volatility 1st Day Turnover
$4.00 1,300,000 Positive High 38.55%

Offering Team

Deal Managers

  • The Benchmark

Lawyers

  • Ellenoff Grossman & Schole LLP

Auditors

  • UHY LLP

Pre-IPO Investors

Investors

  • Google Ventures
  • Intel Ventures
  • Patricoff Ventures
  • Kleiner Perkins

Pre-IPO Holdings(%)

  • 30
  • 20
  • 05
  • 18

Deal Highlights

We are a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. A “white label” gel-based delivery solution is where we produce a product that other companies rebrand as their own product. Our principal products are edible gels, which we refer to as gels, and their application in gel-based dosage forms. Our current product suite c More

Deal Tracker

Investors

Filing

30 Aug, 2022

Offer

29 Oct, 2024

Look Ahead

Lock Up Expiry

29 Apr, 2025

Earning

Nov 1, 2018

IPO Terms

Offer Price $4.00
Offer Size 1M

Market Sentiments

Stock Price